Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of intravenous iclaprim versus intravenous linezolid in complicated skin and skin structure infections
2005-001548-21Phase 3Completed
- Sponsor
- Arpida Ltd
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in Complicated skin and skin structure infection (cSSSI) comparing Intravenous iclaprim with Intravenous linezolid (2 arms). Primary endpoints: Clinical cure rate at test of cure and Safety assessments. Started Jun 2005; status: completed.
02
Drugs
Iclaprimlinezolid
03
Conditions
Complicated skin and skin structure infection (cSSSI)
Beyond the preview
Go deeper on 2005-001548-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001548-21.